onabotulinumtoxin A biosimilar
/ Biocon, Crown Labs
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 23, 2019
Long-term safety and efficacy of open-label onabotulinumtoxina for the treatment of lower limb spasticity in children with cerebral palsy
(AACPDM 2019)
- No abstract available.
1 to 1
Of
1
Go to page
1